GAULT LAURA (Chief Medical Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/7/2024ACC: 0001562180-24-006089
Officer· Chief Medical Officer
Since Oct 2022
+10.21K
Net shares
Net buyer
$29.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
13.50K acquired · 3.29K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.50K
Price / share
—
Trade value
—
% of position
2571.4%
8/5/2024
525.00→14.03K
Common Stock
Direct
Shares
−3.29K
Price / share
$8.96
Trade value
$29.46K
% of position
23.4%
8/5/2024
14.03K→10.74K
Total
Net shares
+10.21K
Net value
-$29.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/5/2024 | A · Award | +13.50K | — | — | 2571.4% | 525.00 | 14.03K |
| Common Stock Direct | 8/5/2024 | F · Tax Withholding | −3.29K | $8.96 | $29.46K | 23.4% | 14.03K | 10.74K |
| Total | +10.21K | -$29.46K | ||||||
Derivative Transactions0
No derivative transactions reported